These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15642706)

  • 21. Troglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma ) ligand, selectively induces the early growth response-1 gene independently of PPAR gamma. A novel mechanism for its anti-tumorigenic activity.
    Baek SJ; Wilson LC; Hsi LC; Eling TE
    J Biol Chem; 2003 Feb; 278(8):5845-53. PubMed ID: 12475986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combinational effect of PPARĪ³ agonist and RXR agonist on the growth of SGC7901 gastric carcinoma cells in vitro.
    Liu Y; Zhu ZA; Zhang SN; Mou J; Liu L; Cui T; Pei DS
    Tumour Biol; 2013 Aug; 34(4):2409-18. PubMed ID: 23605322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxisome proliferator-activated receptors-gamma activator, ciglitazone, inhibits human melanocyte growth through induction of apoptosis.
    Kang HY; Lee JY; Lee JS; Choi YM
    Arch Dermatol Res; 2006 Apr; 297(10):472-6. PubMed ID: 16474974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fenofibrate, troglitazone, and 15-deoxy-Delta12,14-prostaglandin J2 close KATP channels and induce insulin secretion.
    Shimomura K; Shimizu H; Ikeda M; Okada S; Kakei M; Matsumoto S; Mori M
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1273-80. PubMed ID: 15201343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The peroxisome proliferator-activated receptor gamma ligands, pioglitazone and 15-deoxy-Delta(12,14)-prostaglandin J(2), have antineoplastic effects against hepatitis B virus-associated hepatocellular carcinoma cells.
    Shim J; Kim BH; Kim YI; Kim KY; Hwangbo Y; Jang JY; Dong SH; Kim HJ; Chang YW; Chang R
    Int J Oncol; 2010 Jan; 36(1):223-31. PubMed ID: 19956851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of PPAR-gamma ligands in neuroprotection against glutamate-induced cytotoxicity in retinal ganglion cells.
    Aoun P; Simpkins JW; Agarwal N
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):2999-3004. PubMed ID: 12824244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
    Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
    Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ligand activation of peroxisome proliferator-activated receptor gamma induces apoptosis of leukemia cells by down-regulating the c-myc gene expression via blockade of the Tcf-4 activity.
    Yamakawa-Karakida N; Sugita K; Inukai T; Goi K; Nakamura M; Uno K; Sato H; Kagami K; Barker N; Nakazawa S
    Cell Death Differ; 2002 May; 9(5):513-26. PubMed ID: 11973610
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of PPARgamma ligands on the viability of gastric epithelial cells.
    Kojima K; Shimada T; Mitobe Y; Yoshiura K; Hiraishi H; Terano A
    Aliment Pharmacol Ther; 2002 Apr; 16 Suppl 2():67-73. PubMed ID: 11966526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
    Yang FG; Zhang ZW; Xin DQ; Shi CJ; Wu JP; Guo YL; Guan YF
    Acta Pharmacol Sin; 2005 Jun; 26(6):753-61. PubMed ID: 15916743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway.
    Kim EJ; Park KS; Chung SY; Sheen YY; Moon DC; Song YS; Kim KS; Song S; Yun YP; Lee MK; Oh KW; Yoon DY; Hong JT
    J Pharmacol Exp Ther; 2003 Nov; 307(2):505-17. PubMed ID: 12966153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peroxisome proliferator-activated receptor-gamma ligands inhibit proliferation and induce apoptosis in mantle cell lymphoma.
    Eucker J; Sterz J; Krebbel H; Zavrski I; Kaiser M; Zang C; Heider U; Jakob C; Elstner E; Sezer O
    Anticancer Drugs; 2006 Aug; 17(7):763-9. PubMed ID: 16926626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apoptosis in human oral squamous cell carcinomas is induced by 15-deoxy-delta 12,14-prostaglandin J2 but not by troglitazone.
    Fukuchi K; Date M; Azuma Y; Shinohara M; Takahashi H; Ohura K
    J Dent Res; 2003 Oct; 82(10):802-6. PubMed ID: 14514760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The peroxisome proliferator-activated receptor gamma (PPARgamma) ligands 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone induce human B lymphocyte and B cell lymphoma apoptosis by PPARgamma-independent mechanisms.
    Ray DM; Akbiyik F; Phipps RP
    J Immunol; 2006 Oct; 177(8):5068-76. PubMed ID: 17015690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of chondrosarcoma cells by 15-deoxy-Delta 12,14-prostaglandin J2 is associated with altered expression of Bax/Bcl-xL and p21.
    Shen ZN; Nishida K; Doi H; Oohashi T; Hirohata S; Ozaki T; Yoshida A; Ninomiya Y; Inoue H
    Biochem Biophys Res Commun; 2005 Mar; 328(2):375-82. PubMed ID: 15694358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation.
    Asano T; Wakisaka M; Yoshinari M; Iino K; Sonoki K; Iwase M; Fujishima M
    Biochim Biophys Acta; 2000 Jun; 1497(1):148-54. PubMed ID: 10838168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of XIAP sensitizes colon cancer cells to PPARgamma independent antitumor effects of troglitazone and 15-PGJ2.
    Qiao L; Dai Y; Gu Q; Chan KW; Ma J; Lan HY; Zou B; Rocken C; Ebert MP; Wong BC
    Cancer Lett; 2008 Sep; 268(2):260-71. PubMed ID: 18477501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of peroxisome proliferator-activated receptor-gamma induces apoptosis on acute promyelocytic leukemia cells via downregulation of XIAP.
    Liu JJ; Guo YW; Fang ZG; Si XN; Wu XY; Liu PQ; Lin DJ; Xiao RZ; Xu Y; Wang CZ; Li XD; He Y; Huang RW
    Int J Mol Med; 2009 Nov; 24(5):623-32. PubMed ID: 19787196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic effect of 4-hydroxynonenal and PPAR ligands in controlling human leukemic cell growth and differentiation.
    Pizzimenti S; Laurora S; Briatore F; Ferretti C; Dianzani MU; Barrera G
    Free Radic Biol Med; 2002 Feb; 32(3):233-45. PubMed ID: 11827749
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of peroxisome proliferator-activated receptor gamma in renal cell carcinoma and growth inhibition by its agonists.
    Inoue K; Kawahito Y; Tsubouchi Y; Kohno M; Yoshimura R; Yoshikawa T; Sano H
    Biochem Biophys Res Commun; 2001 Sep; 287(3):727-32. PubMed ID: 11563856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.